
    
      Subjects will undergo Excimer treatment twice a week until they reach a PASI 75 improvement,
      or until they reach the maximum of 20 total treatments. A blood draw to assess serum
      inflammatory markers will be performed at the screening visit and final visit. Chromameter
      assessment, photographs, PASI and PGA (Physician Global Assessment) will be performed
      throughout the study to monitor psoriasis improvement, hyperpigmentation and erythema.
    
  